Radiant Innovation Inc. (TPEX:3373)
18.80
-0.20 (-1.05%)
Oct 31, 2025, 1:30 PM CST
Radiant Innovation Revenue
Radiant Innovation had revenue of 100.81M TWD in the quarter ending June 30, 2025, a decrease of -5.24%. This brings the company's revenue in the last twelve months to 418.70M, up 6.66% year-over-year. In the year 2024, Radiant Innovation had annual revenue of 420.53M with 0.49% growth.
Revenue (ttm)
418.70M
Revenue Growth
+6.66%
P/S Ratio
2.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
895.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 420.53M | 2.03M | 0.49% |
| Dec 31, 2023 | 418.50M | -146.06M | -25.87% |
| Dec 31, 2022 | 564.56M | -420.49M | -42.69% |
| Dec 31, 2021 | 985.04M | -1.63B | -62.36% |
| Dec 31, 2020 | 2.62B | 1.83B | 233.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |